The below information outlines the process for the simultaneous review of veterinary medicine submissions to the Australian Pesticides and Veterinary Medicines Authority (APVMA) and the UK's Veterinary Medicines Directorate (VMD).
The Australian Pesticides and Veterinary Medicines Authority (APVMA) invites any person to submit a relevant written submission as to whether the application to permit the use of mefentrifluconazole in the product Belanty Fungicide should be granted. Submissions should relate only to matters that the APVMA is required by legislation to take into account in deciding whether to grant the application. These grounds relate to the trade implications of the extended use of the product. Submissions should state the grounds on which they are based.
The Australian Pesticides and Veterinary Medicines Authority (APVMA) invites comment on the proposed use of pydiflumetofen in the product Miravis Prime Adepidyn Technology Fungicide for use on cherries.
We invite written comment from 3 January 2024 to 31 January 2024 on the trade implications of this proposal.
The Australian Pesticides and Veterinary Medicines Authority (APVMA) is considering an application for approval of the new active constituent, lipoteichoic acid (LTA) from biofilm adhesion component (BAC) of Streptococcus uberis, strain 5616 and the registration of the product, UBAC Inactivated Subunit Vaccine against Streptococcus uberis for Cattle, which is for the active immunisation of healthy cows and heifers to reduce the incidence of clinical intramammary infections caused by Streptococcus uberis, to reduce the somatic cell count in Streptococcus u
